Liver Metastasis Recruiting Phase 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01923987Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant MetastasisTreatment